Top Health-System Trends Highlight SPT Week in Review

5. Age-Related Macular Degeneration Drug Combo Scrapped Despite Safe Profile

Zimura (avacincaptad pegol) was generally well tolerated when given to patients in combination with ranibizumab (Lucentis), but Ophthotech Corp announced it will focus efforts on other clinical programs. Read more.

4. Accelerated Biological Aging from Breast Cancer Treatment May Lead to Cognitive Dysfunction

Study examines whether markers of biological aging due to cancer treatment are related to cognitive function in survivors of breast cancer. Read more.

3. Should Cognitive Function Decline Prompt Changing Multiple Sclerosis Treatments?

Experts argue whether a decline in cognitive function should lead to a change in disease-modifying therapy for multiple sclerosis. Read more.

2. Routine Versus Targeted Hepatitis C Testing in US State Prisons

Study shows that routinely screening inmates for hepatitis C virus at entry may identify a significant number of cases that would have been missed through targeted testing. Read more.

1. Specialty Spending Among Top 5 Health-System Pharmacy Trends to Watch

The specialty drug market saw a 16% growth rate in 2018. Read more.




Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

Top news of the week from Specialty Pharmacy Times.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
Cohesion among key stakeholders, which will lead to an evolution in care, is clearly on the rise, and the growth of those relationships will only benefit patients in the end.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$